Oral Mucormycosis: An Inevitable Complication of COVID-19
- PMID: 35800548
- PMCID: PMC9254828
- DOI: 10.4103/jfmpc.jfmpc_1599_21
Oral Mucormycosis: An Inevitable Complication of COVID-19
Abstract
Individuals who have shown recovery from coronavirus disease (COVID-19) are increasingly getting diagnosed with Mucormycosis or "Black fungus." It is a difficult condition to diagnose as it has symptoms that are common among a variety of diseases. Hence, it is important to identify the presenting signs and understand the underlying pathogenesis of COVID-19 associated Mucormycosis. The incidence of these mycotic infections has shown a substantial increase in current times owing to an increase in the prevalence of immunocompromised subjects, human immunodeficiency virus (HIV) infection, and acquired immunodeficiency syndrome (AIDS). Any suspected case of mucormycosis requires rapid diagnosis and management due to its rapid progression as well as the destructive course of infection. This article reviews the taxonomy, pathogenesis, and clinical signs along with laboratory investigations that may play a vital role in the timely diagnosis of this condition as it is mostly fatal.
Keywords: COVID-19; diagnosis; management; mucormycosis; signs.
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser. 1989;47:243–71. - PubMed
-
- Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G, Chabasse D. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol. 1996;70:76–83. - PubMed
Publication types
LinkOut - more resources
Full Text Sources